Real-life 24-week changes in glycemic parameters among European users of flash glucose monitoring with type 1 and 2 diabetes and different levels of glycemic control

Publikováno v: Diabetes Research and Clinical Practice. 201

AIM: To evaluate real-life changes of glycemic parameters among flash glucose monitoring (FLASH) users who do not meet glycemic targets.METHODS: De-identified data were obtained between 2014 and 2021 from patients using FLASH uninterrupted for a 24-w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dris___01423::07d6cc2029dff9213a337559da710545
https://doi.org/10.1016/j.diabres.2023.110735

Incidence and Characteristics of Remission of Type 2 Diabetes in England: A Cohort Study Using the National Diabetes Audit

Autor: Naomi Holman, Sarah H. Wild, Kamlesh Khunti, Peter Knighton, Jackie O’Keefe, Chirag Bakhai, Bob Young, Naveed Sattar, Jonathan Valabhji, Edward W. Gregg

Publikováno v: Holman, N, Wild, S H, Khunti, K, Knighton, P, O'Keefe, J, Bakhai, C, Young, B, Sattar, N A, Valabhji, J & Gregg, E W 2022, ' Incidence and characteristics of remission of type 2 diabetes in England : A cohort study using the National Diabetes Audit ', Diabetes Care, vol. 45, no. 5, pp. 1151-1161 . https://doi.org/10.2337/dc21-2136
Diabetes Care

OBJECTIVE To assess the incidence of remission of type 2 diabetes in routine care settings. RESEARCH DESIGN AND METHODS People with type 2 diabetes (HbA1c ≥48 mmol/mol [6.5%] or RESULTS In 2,297,700 people with type 2 diabetes, the overall incidenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cee731d3bc860a535df02fe54eb0ba1
https://doi.org/10.2337/dc21-2136

Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol

Autor: Elaine Butterly, Lili Wei, Amanda I Adler, Saleh A M Almazam, Khalid Alsallumi, Luke A K Blackbourn, Sofia Dias, Peter Hanlon, Katherine Hughes, Jim Lewsey, Robert Lindsay, Stuart McGurnaghan, John Petrie, David Phillippo, Naveed Sattar, Laurie A Tomlinson, Nicky Welton, Sarah Wild, David McAllister

Publikováno v: Butterly, E, Wei, L, Adler, A I, Almazam, S A, Alsallumi, K, Blackbourn, L, Dias, S, Peter, H, Hughes, K A, Lewsey, J, Lindsay, R S, McGurnaghan, S, Petrie, J R, Phillippo, D, Sattar, N A, Tomlinson, L, Welton, N J, Wild, S H & McAllister, D A 2022, ' Calibrating a network meta-analysis of diabetes trials of sodium glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population : a systematic review protocol ', BMJ Open, vol. 12, no. 10, 066491, pp. e066491 . https://doi.org/10.1136/bmjopen-2022-066491

IntroductionParticipants in randomised controlled trials (trials) are generally younger and healthier than many individuals encountered in clinical practice. Consequently, the applicability of trial findings is often uncertain. To address this, resul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0969065cc95310742d6794321e8173e1
https://pubmed.ncbi.nlm.nih.gov/36302574

How far along are we in revealing the connection between metformin and colorectal cancer?

Autor: Maja Cigrovski Berković, Ines Bilic-Curcic, Anna Mrzljak, Danko Mikulić

Publikováno v: World Journal of Gastroenterology

Colorectal cancer (CRC) is among the most prevalent cancers worldwide, and its prevention and reduction of incidence is imperative. The presence of diabetes has been associated with a 30% increased risk of CRC, likely through the mechanism of hyperin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c74887ca5d041525bc6edea629ddad
https://doi.org/10.3748/wjg.v27.i14.1362

AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol

Autor: Lee, Tara TM, Collett, Corinne, Man, Mei-See, Hammond, Matt, Shepstone, Lee, Hartnell, Sara, Gurnell, Eleanor, Byrne, Caroline, Scott, Eleanor M, Lindsay, Robert S, Morris, Damian, Brackenridge, Anna, Dover, Anna R, Reynolds, Rebecca M, Hunt, Katharine F, McCance, David R, Barnard-Kelly, Katharine, Rankin, David, Lawton, Julia, Bocchino, Laura E, Sibayan, Judy, Kollman, Craig, Wilinska, Malgorzata E, Hovorka, Roman, Murphy, Helen R, AiDAPT Collaborative Group

Publikováno v: Lee, T, Collett, C, Man, M-S, Hammond, M, Shepstone, L, Hartnell, S, Gurnell, E, Byrne, C, Scott, E M, Lindsay, R, Morris, D, Brackenridge, A, Dover, A, Reynolds, R, Hunt, K, McCrance, D, Barnard-Kelly, K, Rankin, D, Lawton, J, Bocchino, L, Sibayan, J, Kollman, C, Wilinska, M E, Hovorka, R & Murphy, H R 2022, ' AiDAPT: Automated insulin Delivery Amongst Pregnant women with Type 1 diabetes : A multicentre randomized controlled trial – study protocol ', BMC pregnancy and childbirth, vol. 22, no. 1, 282 . https://doi.org/10.1186/s12884-022-04543-z

Background Pregnant women with type 1 diabetes strive for tight glucose targets (3.5-7.8 mmol/L) to minimise the risks of obstetric and neonatal complications. Despite using diabetes technologies including continuous glucose monitoring (CGM), insulin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be95ede108f8062b812aee1441771a60
https://www.repository.cam.ac.uk/handle/1810/336911